William E. Duke
CIK 1636135 · View on SEC EDGAR ↗
First SEC filing: May 20, 2019 · Latest: May 20, 2019
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 18, 2026 | IVVD | S 10b5-1 | 18,425 | $0.84 | $15,477 | 168,937 Direct | -9.83% | Disposed | 8.9% (price as of 2026-08-19) |
| Aug. 17, 2026 | IVVD | S 10b5-1 | 22,355 | $0.72 | $16,096 | 187,362 Direct | -10.66% | Disposed | 27.1% (price as of 2026-08-19) |
| Feb. 18, 2026 | IVVD | S 10b5-1 | 20,964 | $1.58 | $33,123 | 107,717 Direct | -16.29% | Disposed | -42.1% (price as of 2026-08-19) |
| Feb. 17, 2026 | IVVD | S 10b5-1 | 19,663 | $1.54 | $30,281 | 128,681 Direct | -13.26% | Disposed | -40.6% (price as of 2026-08-19) |
| Aug. 19, 2025 | IVVD | S 10b5-1 | 29,643 | $0.57 | $16,897 | 49,344 Direct | -37.53% | Disposed | 60.5% (price as of 2026-08-19) |
| Aug. 18, 2025 | IVVD | S 10b5-1 | 20,013 | $0.65 | $13,008 | 78,987 Direct | -20.22% | Disposed | 40.8% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 15, 2026 | IVVD | Restricted Stock Units | Common Stock (102,000) | — | — | 102,000 | Disposed |
| Feb. 15, 2026 | IVVD | Restricted Stock Units | Common Stock (99,000) | — | — | 99,000 | Disposed |
| Jan. 29, 2026 | IVVD | Stock Option (Right to Buy) | Common Stock (625,000) | $1.85 | Jan. 28, 2036 | 625,000 | Acquired |
| Aug. 15, 2025 | IVVD | Restricted Stock Units | Common Stock (99,000) | — | — | 99,000 | Disposed |
| Feb. 15, 2025 | IVVD | Restricted Stock Units | Common Stock (300,000) | — | — | 300,000 | Acquired |
| Feb. 15, 2025 | IVVD | Stock Option (Right to Buy) | Common Stock (950,000) | $1.61 | Feb. 14, 2035 | 950,000 | Acquired |
| Dec. 18, 2023 | IVVD | Stock Option (Right to Buy) | Common Stock (200,000) | $3.59 | Dec. 17, 2033 | 200,000 | Acquired |
| Sept. 1, 2023 | IVVD | Stock Option (Right to Buy) | Common Stock (750,000) | $1.83 | Aug. 31, 2033 | 750,000 | Acquired |
| May 16, 2019 | PULM | Stock Option (Right to Buy) | Common Stock (160,000) | $1.06 | May 16, 2029 | 160,000 | Acquired |
| June 5, 2018 | PULM | Stock Option (Right to Buy) | Common Stock (850,000) | $0.47 | June 5, 2028 | 850,000 | Acquired |
| March 20, 2017 | PULM | Stock Option (Right to Buy) | Common Stock (75,100) | $2.78 | March 20, 2027 | 75,100 | Acquired |
| Feb. 3, 2016 | PULM | Stock Option (Right to Buy) | Common Stock (150,200) | $2.80 | Feb. 3, 2026 | 150,200 | Acquired |
| June 24, 2015 | PULM | Stock Option (Right to Buy) | Common Stock (235,224) | $11.00 | June 24, 2025 | 235,224 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $347,354 | — | — | — | — | — | $6,079 | $465,271 |
| 2018 | $338,226 | $120,874 | — | — | — | — | $6,022 | $734,577 |
| 2017 | $313,337 | — | — | — | — | — | $5,776 | $518,573 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $485,000 | $256,080 | — | — | — | — | $11,697 | $2,141,222 |
| 2024 | $480,000 | $144,000 | — | — | — | — | $11,543 | $635,543 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.